Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
10.1038/nm910
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J., & Bieniasz, P. D. (2003). Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nature Medicine, 9(9), 1138–1143.

Authors 6
  1. Greg J Towers (first)
  2. Theodora Hatziioannou (additional)
  3. Simone Cowan (additional)
  4. Stephen P Goff (additional)
  5. Jeremy Luban (additional)
  6. Paul D Bieniasz (additional)
References 27 Referenced 326
  1. Hatziioannou, T., Cowan, S., Goff, S.P., Bieniasz, P.D. & Towers, G. Restriction of multiple divergent retroviruses by Lv-1 and Ref1. EMBO J. 22, 385–394 (2003). (10.1093/emboj/cdg042) / EMBO J. by T Hatziioannou (2003)
  2. Besnier, C., Takeuchi, Y. & Towers, G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99, 11920–11925 (2002). (10.1073/pnas.172384599) / Proc. Natl. Acad. Sci. USA by C Besnier (2002)
  3. Cowan, S. et al. Cellular inhibitors with Fv-1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99, 11914–11919 (2002). (10.1073/pnas.162299499) / Proc. Natl. Acad. Sci. USA by S Cowan (2002)
  4. Munk, C., Brandt, S.M., Lucero, G. & Landau, N.R. A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc. Natl. Acad. Sci. USA 99, 13843–13848 (2002). (10.1073/pnas.212400099) / Proc. Natl. Acad. Sci. USA by C Munk (2002)
  5. Towers, G. et al. A conserved mechanism of retrovirus restriction in mammals. Proc. Natl. Acad. Sci. USA 97, 12295–12299 (2000). (10.1073/pnas.200286297) / Proc. Natl. Acad. Sci. USA by G Towers (2000)
  6. Towers, G., Collins, M. & Takeuchi, Y. Abrogation of Ref1 retrovirus restriction in human cells. J. Virol. 76, 2548–2550 (2002). (10.1128/jvi.76.5.2548-2550.2002) / J. Virol. by G Towers (2002)
  7. Dorfman, T. & Gottlinger, H.G. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70, 5751–5757 (1996). (10.1128/JVI.70.9.5751-5757.1996) / J. Virol. by T Dorfman (1996)
  8. DesGroseillers, L. & Jolicoeur, P. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J. Virol. 48, 685–696 (1983). (10.1128/JVI.48.3.685-696.1983) / J. Virol. by L DesGroseillers (1983)
  9. Kozak, C.A. & Chakraborti, A. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv-1 resistance. Virology 225, 300–305 (1996). (10.1006/viro.1996.0604) / Virology by CA Kozak (1996)
  10. Luban, J., Bossolt, K.L., Franke, E.K., Kalpana, G.V. & Goff, S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73, 1067–1078 (1993). (10.1016/0092-8674(93)90637-6) / Cell by J Luban (1993)
  11. Thali, M. et al. Functional association of cyclophilin A with HIV-1 virions. Nature 372, 363–365 (1994). (10.1038/372363a0) / Nature by M Thali (1994)
  12. Franke, E.K., Yuan, H.E. & Luban, J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372, 359–362 (1994). (10.1038/372359a0) / Nature by EK Franke (1994)
  13. Yoo, S. et al. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269, 780–795 (1997). (10.1006/jmbi.1997.1051) / J. Mol. Biol. by S Yoo (1997)
  14. Braaten, D. & Luban, J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J. 20, 1300–1309 (2001). (10.1093/emboj/20.6.1300) / EMBO J. by D Braaten (2001)
  15. Braaten, D., Franke, E.K. & Luban, J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70, 3551–3560 (1996). (10.1128/JVI.70.6.3551-3560.1996) / J. Virol. by D Braaten (1996)
  16. Braaten, D., Franke, E.K. & Luban, J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70, 4220–4227 (1996). (10.1128/JVI.70.7.4220-4227.1996) / J. Virol. by D Braaten (1996)
  17. Shibata, R., Sakai, H., Kawamura, M., Tokunaga, K. & Adachi, A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J. Gen. Virol. 76, 2723–2730 (1995). (10.1099/0022-1317-76-11-2723) / J. Gen. Virol. by R Shibata (1995)
  18. Clipstone, N.A. & Crabtree, G.R. Identification of calcineurin as a key signalling enzyme in T- lymphocyte activation. Nature 357, 695–697 (1992). (10.1038/357695a0) / Nature by NA Clipstone (1992)
  19. Braaten, D. et al. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J. Virol. 70, 5170–5176 (1996). (10.1128/JVI.70.8.5170-5176.1996) / J. Virol. by D Braaten (1996)
  20. Franke, E.K. & Luban, J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222, 279–282 (1996). (10.1006/viro.1996.0421) / Virology by EK Franke (1996)
  21. Aiken, C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871–5877 (1997). (10.1128/JVI.71.8.5871-5877.1997) / J. Virol. by C Aiken (1997)
  22. Goff, S.P. Operating under a Gag order: a block against incoming virus by the Fv-1 gene. Cell 86, 691–693 (1996). (10.1016/S0092-8674(00)80141-5) / Cell by SP Goff (1996)
  23. Stoye, J.P. An intracellular block to primate lentivirus replication. Proc. Natl. Acad. Sci. USA 99, 11549–11551 (2002). (10.1073/pnas.192449399) / Proc. Natl. Acad. Sci. USA by JP Stoye (2002)
  24. Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646–650 (2002). (10.1038/nature00939) / Nature by AM Sheehy (2002)
  25. Kootstra, N.A., Munk, C., Tonnu, N., Landau, N.R. & Verma, I.M. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc. Natl. Acad. Sci. USA 100, 1298–1303 (2003). (10.1073/pnas.0337541100) / Proc. Natl. Acad. Sci. USA by NA Kootstra (2003)
  26. Bukovsky, A.A., Weimann, A., Accola, M.A. & Gottlinger, H.G. Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc. Natl. Acad. Sci. USA 94, 10943–10948 (1997). (10.1073/pnas.94.20.10943) / Proc. Natl. Acad. Sci. USA by AA Bukovsky (1997)
  27. Wiegers, K. & Krausslich, H.G. Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. Virology 294, 289–295 (2002). (10.1006/viro.2001.1347) / Virology by K Wiegers (2002)
Dates
Type When
Created 22 years ago (Aug. 1, 2003, 10:10 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:34 p.m.)
Indexed 1 month, 4 weeks ago (June 24, 2025, 11:13 a.m.)
Issued 22 years ago (Aug. 3, 2003)
Published 22 years ago (Aug. 3, 2003)
Published Online 22 years ago (Aug. 3, 2003)
Published Print 21 years, 11 months ago (Sept. 1, 2003)
Funders 0

None

@article{Towers_2003, title={Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors}, volume={9}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/nm910}, DOI={10.1038/nm910}, number={9}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Towers, Greg J and Hatziioannou, Theodora and Cowan, Simone and Goff, Stephen P and Luban, Jeremy and Bieniasz, Paul D}, year={2003}, month=aug, pages={1138–1143} }